Javitt Jonathan C bought NRXP
April 9, 2025 · Form 4 insider transaction
Javitt Jonathan C bought 125,000 shares of NRx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 154 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderJavitt Jonathan C
RoleOfficer, Director, 10% owner
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 9, 2025
Filing dateSeptember 10, 2025
Shares owned after125,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. 1/3 of the Options shall vest on the first anniversary of the grant date, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to continued